Patents by Inventor Carolyn L. CANNON
Carolyn L. CANNON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230346697Abstract: The claimed invention is directed to the use of a composition for use as an antimicrobial comprising an antimicrobial agent. In certain embodiments, the composition is used for treating or ameliorating inflammation in a subject and comprises an anti-inflammatory agent. The anti-inflammatory agent may include an NSAID, such as ibuprofen or diclofenac. The composition may further include solvents, anti-bacterial agents, anti-fungal agents, anti-parasitic agents, anti-viral agents, and buffers. The composition may include particles that have been processed via jet milling to reduce a diameter of the particles and to improve a flowability of the particles.Type: ApplicationFiled: July 7, 2023Publication date: November 2, 2023Inventors: Carolyn L. Cannon, Parth N. Shah, Justin A. Smolen, Hugh D. Smyth, Ashkan K. Yazdi, Matthew J. Herpin
-
Patent number: 11723864Abstract: The claimed invention is directed to the use of a composition for use as an antimicrobial comprising an antimicrobial agent. In certain embodiments, the composition is used for treating or ameliorating inflammation in a subject and comprises an anti-inflammatory agent. The anti-inflammatory agent may include an NSAID, such as ibuprofen or diclofenac. The composition may further include solvents, anti-bacterial agents, anti-fungal agents, anti-parasitic agents, anti-viral agents, and buffers. The composition may include particles that have been processed via jet milling to reduce a diameter of the particles and to improve a flowability of the particles.Type: GrantFiled: May 29, 2016Date of Patent: August 15, 2023Assignees: The Texas A&M University System, The Board of Regents of the University of Texas SystemInventors: Carolyn L. Cannon, Parth N. Shah, Justin A. Smolen, Hugh D. Smyth, Ashkan K. Yazdi, Matthew J. Herpin
-
Publication number: 20220183994Abstract: In an embodiment, a drug delivery system and method of use thereof to treat inflammation and bacterial pathogens including multi-drug resistant pathogens, such as MDR-Pseudomonas aeruginosa, or reactive oxygen species in a subject is provided. In some embodiments, the drug delivery system includes a polymeric material, an excepient, an antioxidant agent, and an anti-inflammatory and antimicrobial agent. In some embodiments, the anti-inflammatory and antimicrobial agent is a salt of an anti-inflammatory agent and an antimicrobial agent formulated to provide a combination of antimicrobial and anti-inflammatory action from a single molecule. In some embodiments, the combined anti-inflammatory and antimicrobial agent is a silver salt of ibuprofen. In other embodiments, the combined anti-inflammatory and antimicrobial agent is unmodified, native ibuprofen.Type: ApplicationFiled: April 3, 2020Publication date: June 16, 2022Inventors: Carolyn L. Cannon, Kush Shah, Bhagath Chirra, Qingquan Chen, Mansoor Khan, Hung-Jen Wu
-
Publication number: 20190202774Abstract: In one aspect, the present disclosure provides diaryl compounds of the formula presented herein. The application also provides compositions and methods of treatment thereof. In some embodiments, these compounds are used in the treatment of bacterial infections or in the treatment of cancer.Type: ApplicationFiled: November 11, 2016Publication date: July 4, 2019Applicants: WILLIAM MARSH RICE UNIVERSITY, THE TEXAS A&M UNIVERSITY SYSTEM, THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEMInventors: Hongyin GAO, Laszlo KURTI, Kush SHAH, Parth SHAH, Carolyn L CANNON
-
Publication number: 20180207093Abstract: The claimed invention is directed to the use of a composition for use as an antimicrobial comprising an antimicrobial agent. In certain embodiments, the composition is used for treating or ameliorating inflammation in a subject and comprises an anti-inflammatory agent. The anti-inflammatory agent may include an NSAID, such as ibuprofen or diclofenac. The composition may further include solvents, anti-bacterial agents, anti-fungal agents, anti-parasitic agents, anti-viral agents, and buffers. The composition may include particles that have been processed via jet milling to reduce a diameter of the particles and to improve a flowability of the particles.Type: ApplicationFiled: May 29, 2016Publication date: July 26, 2018Applicants: The Texas A&M University System, Th Board of Regents of the University of Texas SystemInventors: Carolyn L. Cannon, Parth N. Shah, Justin A. Smolen, Hugh D. Smyth, Ashkan K. Yazdi, Matthew J. Herpin
-
Patent number: 8648064Abstract: The present invention generally relates to metal complexes of N-heterocyclic carbenes that contain one or more additional active moieties and/or groups therein. In one embodiment, the present invention relates to metal complexes of N-heterocyclic carbenes that contain an anti-fungal and/or anti-microbial moiety and/or group in combination with one or more additional active moieties and/or groups selected from fluoroquinolone compounds or derivatives thereof; steroids or derivatives thereof; anti-inflammatory compounds or derivatives thereof; anti-fungal compounds or derivatives thereof; anti-bacterial compounds or derivatives thereof; antagonist compounds or derivatives thereof; H2 receptor compounds or derivatives thereof; chemotherapy compounds or derivatives thereof; tumor suppressor compounds or derivatives thereof; or C1 to C16 alkyl heteroatom groups where the heterotatom is selected from S, O, or N.Type: GrantFiled: October 12, 2010Date of Patent: February 11, 2014Assignee: The University of AkronInventors: Wiley J. Youngs, Matthew J. Panzner, Carolyn L. Cannon
-
Patent number: 8648205Abstract: The present invention generally relates to metal complexes of N-heterocyclic carbenes that contain one or more additional active moieties and/or groups therein. In one embodiment, the present invention relates to metal complexes of N-heterocyclic carbenes that contain an anti-fungal and/or anti-microbial moiety and/or group in combination with one or more additional active moieties and/or groups selected from fluoroquinolone compounds or derivatives thereof; steroids or derivatives thereof; anti-inflammatory compounds or derivatives thereof; anti-fungal compounds or derivatives thereof; anti-bacterial compounds or derivatives thereof; antagonist compounds or derivatives thereof; H2 receptor compounds or derivatives thereof; chemotherapy compounds or derivatives thereof; tumor suppressor compounds or derivatives thereof; or C1 to C16 alkyl heteroatom groups where the heterotatom is selected from S, O, or N.Type: GrantFiled: February 4, 2011Date of Patent: February 11, 2014Assignee: The University of AkronInventors: Wiley J. Youngs, Matthew J. Panzner, Carolyn L. Cannon
-
Publication number: 20110306585Abstract: The present invention generally relates to metal complexes of N-heterocyclic carbenes that contain one or more additional active moieties and/or groups therein. In one embodiment, the present invention relates to metal complexes of N-heterocyclic carbenes that contain an anti-fungal and/or anti-microbial moiety and/or group in combination with one or more additional active moieties and/or groups selected from fluoroquinolone compounds or derivatives thereof; steroids or derivatives thereof; anti-inflammatory compounds or derivatives thereof; anti-fungal compounds or derivatives thereof; anti-bacterial compounds or derivatives thereof; antagonist compounds or derivatives thereof; H2 receptor compounds or derivatives thereof; chemotherapy compounds or derivatives thereof; tumor suppressor compounds or derivatives thereof; or C1 to C16 alkyl heteroatom groups where the heterotatom is selected from S, O, or N.Type: ApplicationFiled: February 4, 2011Publication date: December 15, 2011Applicant: THE UNIVERISTY OF AKRONInventors: Wiley J. YOUNGS, Matthew J. PANZNER, Carolyn L. CANNON
-
Publication number: 20110086830Abstract: The present invention generally relates to metal complexes of N-heterocyclic carbenes that contain one or more additional active moieties and/or groups therein. In one embodiment, the present invention relates to metal complexes of N-heterocyclic carbenes that contain an anti-fungal and/or anti-microbial moiety and/or group in combination with one or more additional active moieties and/or groups selected from fluoroquinolone compounds or derivatives thereof; steroids or derivatives thereof; anti-inflammatory compounds or derivatives thereof; anti-fungal compounds or derivatives thereof; anti-bacterial compounds or derivatives thereof; antagonist compounds or derivatives thereof; H2 receptor compounds or derivatives thereof; chemotherapy compounds or derivatives thereof; tumor suppressor compounds or derivatives thereof; or C1 to C16 alkyl heteroatom groups where the heterotatom is selected from S, O, or N.Type: ApplicationFiled: October 12, 2010Publication date: April 14, 2011Applicant: THE UNIVERSITY OF AKRONInventors: Wiley J. YOUNGS, Matthew J. PANZNER, Carolyn L. CANNON